SCHOLAR ROCK HOLDING CORP Share Price Today: Live Updates & Key Insights
SCHOLAR ROCK HOLDING CORP share price today is $45.11, up -1.89%. The stock opened at $45.93 against the previous close of $45.5, with an intraday high of $47.75 and low of $44.11.
SCHOLAR ROCK HOLDING CORP Share Price Chart
SCHOLAR ROCK HOLDING CORP
SCHOLAR ROCK HOLDING CORP Share Price Performance
SCHOLAR ROCK HOLDING CORP Institutional Holdings
SCHOLAR ROCK HOLDING CORP Market Status
SCHOLAR ROCK HOLDING CORP Fundamentals
Market Cap 5128.38 M
PB Ratio 20.8906
PE Ratio 0.0
Enterprise Value 4869.73 M
Total Assets 404.27 M
Volume 3288473
SCHOLAR ROCK HOLDING CORP Company Financials
About SCHOLAR ROCK HOLDING CORP & investment objective
Company Information Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. The company's novel understanding of the molecular mechanisms of growth factor activation within the transforming growth factor beta (TGFß) superfamily has enabled the development of a proprietary platform. This platform is used for the development of monoclonal antibodies that locally and selectively target the precursor, or latent, forms of growth factors. The company is developing Apitegromab, an inhibitor of the activation of myostatin, which is in a Phase 2 clinical trial for the treatment of SMA and facioscapulohumeral muscular dystrophy (FSHD). Additionally, SRK-439, an anti-pro/latent myostatin antibody, is in a Phase 1 clinical trial for the treatment of patients with rare, severe, and debilitating neuromuscular diseases. SRK-181 is a Phase 2-ready investigational inhibitor of latent TGFß1 for the treatment of patients with solid tumors that are resistant to anti-PD-(L)1 antibody therapies. The company also offers products in pre-clinical development, including SRK-373, a selective inhibitor of the latent TGFß1 isoform with selective activity in the fibrotic extracellular matrix, for the treatment of fibrotic diseases, and SRK-256, an inhibitor of RGMc, or hemojuvelin, for the treatment of iron-restricted anemias. Scholar Rock Holding Corporation is also developing a pipeline that includes programs for the treatment of patients with rare, severe, and debilitating neuromuscular diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Organisation Biotechnology
Employees 289
Industry Biotechnology
CEO Mr. David L. Hallal
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
SCHOLAR ROCK HOLDING CORP FAQs
What is the share price of SCHOLAR ROCK HOLDING CORP today?
The current share price of SCHOLAR ROCK HOLDING CORP is $45.11.
Can I buy SCHOLAR ROCK HOLDING CORP shares in India?
Yes, Indian investors can buy SCHOLAR ROCK HOLDING CORP shares by opening an international trading and demat account with Motilal Oswal.
How to buy SCHOLAR ROCK HOLDING CORP shares in India?
You can easily invest in SCHOLAR ROCK HOLDING CORP shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy SCHOLAR ROCK HOLDING CORP shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of SCHOLAR ROCK HOLDING CORP.
Can I buy fractional shares of SCHOLAR ROCK HOLDING CORP?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of SCHOLAR ROCK HOLDING CORP?
SCHOLAR ROCK HOLDING CORP has a market cap of $5128.38 M.
In which sector does SCHOLAR ROCK HOLDING CORP belong?
SCHOLAR ROCK HOLDING CORP operates in the Biotechnology sector.
What documents are required to invest in SCHOLAR ROCK HOLDING CORP stocks?
To invest, you typically need:
What is the PE and PB ratio of SCHOLAR ROCK HOLDING CORP?
The PE ratio of SCHOLAR ROCK HOLDING CORP is N/A and the PB ratio is 20.89.